MACROLYTIC RAS INHIBITORS

CR20260137APending Publication Date: 2026-06-01REVOLUTION MEDICINES INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: CR202600137
Authority / Receiving Office: CR · CR
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2024-10-11
Filing Date: 2024-10-11
Publication Date: 2026-06-01

Application Information

Patent Timeline

11 Oct 2024

Priority

11 Oct 2024

Application

CR202600137

01 Jun 2026

Publication

CR20260137A

IPC: A61K31/504; A61K31/5025; A61K31/506; A61K31/5377; A61K45/06; A61P35/00; C07D498/22; C07D513/22; C07D515/22; C07D519/00; C07K5/062

CPC: A61P35/00; C07D498/22; C07D515/22; C07D519/00; A61K31/5025; A61K31/5377; C07D513/22; A61K31/504

Inventors: GILL Adrian L.; TOMLINSON Aidan

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The description outlines macrocyclic compounds, and pharmaceutical compositions and protein complexes thereof, capable of inhibiting Ras proteins, and their uses in the treatment of cancers.

Need to check novelty before this filing date? Find Prior Art